Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
October 01, Wednesday 2014 9:28 AM       
       HEADLINES: CPI State conference in Kottayam                                              12 blacklisted pharma companies enter Kerala market                                              Khem Cho Mr PM? Obama asks Modi                                              Mango crème brulee for Modi at Obama dinner                                              Indian Muslims will fail al-Qaeda: Modi                                              Diesel price likely to be cut after five years                                              Suspended IAS officer arrested in corruption case                                              Search for missing flight MH370 to resume                                              Modi gifts Gita, Martin Luther King's memorabilia to Obama                                              Modi, Obama write first joint editorial                                              Intruder ran deep into White House: Report                                              Indian-origin politician in race to become Portugal PM                                              Sania-Saketh win mixed doubles gold; India maintain 9th place                                              Mary Kom leads women boxers charge into Asiad medal round                                              Akashdeep ends India's 12-year final jinx in Asiad hockey                                              Kaumudi Facebook
       BUSINESS Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter  
       Ranbaxy recalls over 64,000 bottles of generic Lipitor in US
 
         Posted on :22:10:56 Mar 8, 2014
   
A A
       Last edited on:22:10:56 Mar 8, 2014
         Tags: Ranbaxy, Lipitor in US
 

NEW DELHI: Drug major Ranbaxy Laboratories has recalled over 64,000 bottles of Atorvastatin calcium tablets, a generic version of cholesterol-lowering drug Lipitor, after a complaint of wrong dosage.

The Indian firm, which is reeling under regulatory action from the US Food and Drug Administration (USFDA), recalled the drug after a complaint by a pharmacist who discovered a 20 mg tablet inside a sealed bottle of Atorvastatin 10 mg tablets.

"Ranbaxy Pharmaceuticals is conducting a voluntary recall in the US limited to two lots of Atorvastatin calcium tablets, 10 mg manufactured in India which expire in May 2014," it said in a statement.

The company, majority owned by Japan's Daiichi Sankyo, said it recalled the tablets "because of a remote possibility of the presence of a 20 mg Atorvastatin calcium tablet in a 10 mg bottle."

"This is the basis of the voluntary recall," it added.

To date, Ranbaxy has not received any product complaints related to these batches, the company said.

"Other lot numbers, package sizes and strengths are not affected by this recall. The recall is being conducted at the retail level," it added.

Ranbaxy is withdrawing the lots out of abundant caution, keeping the safety of patients in mind and with full knowledge of the USFDA, it said.

In January, the USFDA prohibited Ranbaxy from producing and distributing drugs for the American market from its Toansa facility in Punjab.

The Toansa plant catered to over 70 per cent of Ranbaxy's requirement for raw material used in medicine formulations. Toansa was the fourth Ranbaxy plant banned by the USFDA.

In September, the USFDA imposed an import alert on Ranbaxy's Mohali plant in Punjab for violating good manufacturing norms.

Ranbaxy's key facilities at Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh have been under a US import alert since 2008.

A A
       BUSINESS
Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter
 
 
BUSINESS HEADLINES
Maruti to recall 69,555 units of old Dzire and Swift, Ritz  
Accept self-attested documents to open account: RBI to banks  
RBI keeps interest rates unchanged  
Govt cancels SEZs of Hindalco, Essar, Adani  
Sensex falls 29pts ahead of RBI policy;IT shares up on weak Re  
Jan Dhan accounts cross 5cr mark, banks collect over Rs 3500cr  
Gold glitters on festive demand, up Rs 590  
S&P betters India's credit outlook to stable from negative  
Bullish on India, asset managers see billions of $ flowing in  
Indian bourses can help raise $100-150 bn capital every year:BSE  
Sensex drops 276 pts to 1-mth low; oil, metal stocks bleed  
Pizza chain Sbarro to open 40 outlets in India by 2019  
Sensex recovers 50 pts in early trade on select buying  
India's steel production grows by 1.7% in August  
Oil prices up after upbeat Chinese data, Syria bombing  
Sensex trades flat, IT stocks gain  
Gold extends losses, down Rs 120 on global cues, weak demand  
Nepal clears GMR's USD 1.5 billion Hydel project  
Gold hits 14-month low, dips below 27k level  
RBI tells banks to be careful about Jan Dhan Yojana  
Gold tumbles by Rs 440, dips to over 3-mth low on global cues  
Bosch: Strike enters 4th day, union seeks govt intervention  
EPFO makes it mandatory to provide workers' bank a/c numbers  
Mkts cheer Fed policy, China ties; Indices up most in 3 mths  
SBI controls half the mobile banking share  
 
Film stars have staged a protest in Chennai against jailing of Jayalalithaa. Is this a right move?
Yes
 
No
 
Don't know
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy